The RM Catalyst consortium recently published two reports revealing Australia’s potential to become a global leader in the regenerative medicine sector.
With a reputation for delivering high-quality, complex, and safe medical products, as well as a highly-skilled workforce, the reports highlights how Australia can become a clinical trial and manufacturing hub to deliver potentially life-changing treatments to patients, both locally and globally.
